Long-term HBsAg clearance, relapse, and safety following tenofovir or entecavir discontinuation in non-cirrhotic, HBeAg-negative chronic hepatitis.

Sci Rep · 2026 · PMC13031601 · PMID 41735396

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

In contrast, a retrospective cohort of 194 Chinese patients who stopped ETV therapy found only a nonsignificant trend toward lower EOT HBsAg levels as a predictor of HBsAg clearance.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.